Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
12/21/1995 | WO1995034300A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same |
12/21/1995 | CA2192460A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
12/21/1995 | CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
12/19/1995 | US5476856 Treatment of PAF and histamine-mediated diseases with 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
12/19/1995 | US5476847 Treating cardiovascular, gastrointestinal, urogenital disorders |
12/19/1995 | US5476846 Administering anti-thrombotic and anti-asthmatic agent |
12/14/1995 | WO1995033763A1 Novel elastase inhibitors |
12/14/1995 | WO1995033762A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
12/14/1995 | WO1995033752A1 Endothelin receptor antagonists |
12/14/1995 | WO1995033750A1 Corticotropin releasing factor antagonists |
12/14/1995 | WO1995033744A1 Tachykinin (nk1) receptor antagonists |
12/14/1995 | WO1995033712A1 Anti-inflammatory compounds |
12/14/1995 | WO1995033682A1 Process and filter for producing no2-free nitrogen monoxide with sulphurous polymers |
12/14/1995 | WO1995033478A1 Acylated enol derivatives as prodrugs of elastase inhibitors |
12/14/1995 | WO1995033467A2 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications |
12/14/1995 | WO1995033461A1 Anti-inflammatory compounds |
12/14/1995 | DE4419860A1 Verfahren und Filter zur Herstellung von NO¶2¶-freiem Stickstoffmonoxid mit schwefelhaltigen Polymeren Technology and process for the production of NO¶2¶-free nitric oxide with sulfur-containing polymers |
12/14/1995 | CA2192069A1 Process and filter for producing no2-free nitrogen monoxide with sulphurous polymers |
12/14/1995 | CA2191960A1 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications |
12/14/1995 | CA2187531A1 Tachykinin (nk1) receptor antagonists |
12/13/1995 | EP0686629A2 Cyclohexyl tachykinine receptor antagonists |
12/13/1995 | EP0686627A2 Substituted perfluoroalkylguanidines, process for their preparation, their use as medicine or diagnostic as well as medicines containing them |
12/12/1995 | US5475015 Benzimidazole derivatives, their preparation and pharmaceutical use |
12/12/1995 | US5474995 Phenyl heterocycles as cox-2 inhibitors |
12/12/1995 | US5474774 Adhesion inhibiting composition |
12/12/1995 | US5474760 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers |
12/12/1995 | US5474759 Non-chlorofluorocarbon aerosol formulations |
12/11/1995 | CA2151113A1 Imidazolinyl tachykinin receptor antagonists |
12/11/1995 | CA2150992A1 Cyclohexyl tachykinin receptor antagonists |
12/07/1995 | WO1995032992A1 Synthetic peptide analogs of lung surfactant protein sp-c |
12/07/1995 | WO1995032972A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
12/07/1995 | WO1995032971A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF |
12/07/1995 | WO1995032970A1 (a)-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
12/07/1995 | WO1995032948A1 Quinoline derivatives as tachykinin nk3 receptor antagonists |
12/07/1995 | WO1995032945A1 Compositions and methods for treating mast-cell mediated conditions |
12/07/1995 | WO1995032727A1 Inhibition of infection of mammalian cells by respiratory syncytial virus |
12/07/1995 | DE4419315A1 New hetero- and oxo-pyrrolizine derivs. |
12/07/1995 | DE4419247A1 New pyrrolizine keto-acid, keto-ester and carboxamide derivs. |
12/07/1995 | DE4419246A1 New hetero-aryl substd. pyrrolizine derivs. |
12/07/1995 | CA2191745A1 [a]-annelated pyrrole derivatives and pharmaceutical uses thereof |
12/07/1995 | CA2190609A1 Inhibition of infection of mammalian cells by respiratory syncytial virus |
12/06/1995 | EP0685475A1 Amino-benzofuryl-and thienyl-derivatives |
12/06/1995 | EP0685474A1 Oxalylamino-benzofuran- and benzothienyl-derivatives |
12/06/1995 | EP0445255B1 Treatment of conditions and disease |
12/05/1995 | US5473054 IGF-1 analogs |
12/05/1995 | US5472964 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
12/05/1995 | US5472002 Cigarette filter for administering taurine by inhalation |
12/01/1995 | CA2150301A1 Oxalylamino-benzofuran-and benzothienyl-derivatives |
12/01/1995 | CA2150300A1 Amino-benzofuryl- and thienyl-derivatives |
11/30/1995 | WO1995032218A1 Neurotensin antagonist peptides |
11/30/1995 | WO1995032217A1 Peptide antagonist intermediates of neurotensin |
11/30/1995 | WO1995031964A1 Fluticasone propionate formulations |
11/30/1995 | CA2190763A1 Fluticasone propionate formulations |
11/29/1995 | EP0684257A1 Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them |
11/28/1995 | US5470885 Respriatory, gastrointestinal |
11/28/1995 | US5470882 Diphenylsulfide with urea and sulfonates |
11/28/1995 | US5470872 Muscle relaxants |
11/28/1995 | US5470855 Certain heterocyclic thiazole derivatives and their therapeutic use |
11/28/1995 | CA1337655C 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-¬(substituted amino)carbonyl|-2-thioxo(or oxo)-5-pyrimidinecarboxylic acids and esters |
11/23/1995 | WO1995031451A1 Novel compounds |
11/23/1995 | WO1995031437A1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
11/23/1995 | WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
11/23/1995 | WO1995031191A1 Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders |
11/23/1995 | CA2189528A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
11/22/1995 | EP0682950A1 Mucosal administration of pneumococcal antigens |
11/22/1995 | EP0682662A1 Bicyclic carboxylic acid leukotriene b 4? antagonists |
11/22/1995 | EP0682526A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS |
11/22/1995 | EP0682514A1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
11/22/1995 | CN1112122A Sulfated-glycolipid derivatives as cell adhesion inhibitors |
11/22/1995 | CN1111994A Antiasthmatic paper stuck on acupoint |
11/21/1995 | US5468897 Bi-aromatic esters, a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions |
11/21/1995 | US5468757 For treating stroke or myocardial infarction in humans |
11/21/1995 | US5468756 Antiinflammatory, antiallergen |
11/21/1995 | US5468744 Composition comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use |
11/21/1995 | US5468731 Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same |
11/21/1995 | CA2149703A1 Mucosal administration of pneumococcal antigens |
11/16/1995 | WO1995030900A1 MODULATORS OF CYTOKINES OF THE TGF-β SUPERFAMILY AND METHODS FOR ASSAYING FOR SAME |
11/16/1995 | WO1995030687A1 Neurokinine (tachykinine) antagonists |
11/16/1995 | WO1995030428A1 Human dnase |
11/16/1995 | WO1995030415A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
11/16/1995 | WO1995028418A3 Tachykinin antagonists |
11/16/1995 | CA2189764A1 Neurokinine (tachykinine) antagonists |
11/16/1995 | CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same |
11/16/1995 | CA2189336A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
11/15/1995 | EP0682028A1 5,6-Dihydro-4H-thieno 3,4-C pyrroleerivatives, their preparation and their therapeutic use |
11/15/1995 | EP0681833A2 Nasally administrable compositions |
11/15/1995 | EP0681589A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
11/15/1995 | EP0681571A1 Spiro-substituted azacycles as tachykinin receptor antagonists |
11/15/1995 | EP0238545B1 C20 through c26 amino steroids |
11/15/1995 | CN1111508A Fatty acid derivatives |
11/15/1995 | CN1030251C Substituted 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives |
11/14/1995 | US5466826 Process for preparing a physical form of pharmaceutical agent |
11/14/1995 | US5466823 Antiinflammatory agents; FDA Orange book listed patent for Celebrex |
11/14/1995 | US5466697 8-phenyl-1,6-naphthyridin-5-ones |
11/14/1995 | US5466451 Carbon dioxide, supercritical |
11/11/1995 | CA2148880A1 5,6-dihydro-4h-thieno[3,4-c]pyrrole derivatives; process for preparing the same and their use as therapeutic agents |
11/09/1995 | WO1995029694A1 Collagen hydrolysis accelerator |
11/09/1995 | WO1995029682A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWIS?a¿ |
11/09/1995 | WO1995029672A1 HALOMETHYL AMIDES AS IL-1β PROTEASE INHIBITORS |
11/09/1995 | CA2189036A1 Halomethyl amides as il-1.beta. protease inhibitors |